Your browser doesn't support javascript.
[Anti-IL-6 receptor antibody treatment for severe COVID-19 and the potential implication of IL-6 gene polymorphisms in novel coronavirus pneumonia]. / Tratamiento con anticuerpos anti-receptor de IL-6 para COVID-19 grave y la posible implicación de polimorfismos del gen IL-6 en la nueva neumonía por coronavirus.
Ulhaq, Zulvikar Syambani; Soraya, Gita Vita.
  • Ulhaq ZS; Department of Biochemistry, Faculty of Medicine and Health Sciences, Maulana Malik Ibrahim Islamic State University of Malang, Batu, East Java 65151, Indonesia. Electronic address: zulhaq@kedokteran.uin-malang.ac.id.
  • Soraya GV; Department of Biochemistry, Faculty of Medicine, Hasanuddin University, Makassar, South Sulawesi 90245, Indonesia.
Med Clin (Barc) ; 155(12): 548-556, 2020 12 24.
Article in English, Spanish | MEDLINE | ID: covidwho-641620

Full text: Available Collection: International databases Database: MEDLINE Main subject: Interleukin-6 / Promoter Regions, Genetic / Receptors, Interleukin-6 / Polymorphism, Single Nucleotide / Antibodies, Monoclonal, Humanized / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Type of study: Observational study / Prognostic study / Randomized controlled trials / Reviews Limits: Adult / Female / Humans / Male / Middle aged Language: English / Spanish Journal: Med Clin (Barc) Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Interleukin-6 / Promoter Regions, Genetic / Receptors, Interleukin-6 / Polymorphism, Single Nucleotide / Antibodies, Monoclonal, Humanized / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Type of study: Observational study / Prognostic study / Randomized controlled trials / Reviews Limits: Adult / Female / Humans / Male / Middle aged Language: English / Spanish Journal: Med Clin (Barc) Year: 2020 Document Type: Article